Polycystic ovary syndrome (PCOS) was hypothesized to result from functional ovarian
hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989–1995 …

Polycystic ovary syndrome (PCOS) has multiple etiologies including ovarian and adrenal
hyperandrogenism, neuro-endocrine and hypothalamic-pituitary dysfunction, and disorders …

Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine disorder with the
underline indication of ovarian cysts, anovulation, and endocrine variation affecting the …

Objective Our objective was to formulate a clinical practice guideline for the management of
the pregnant woman with diabetes. Participants The Task Force was composed of a chair …

Context The comparative effectiveness of drugs and surgical therapy for women with obesity
and polycystic ovary syndrome (PCOS) has not been systematically compared. Objective …

The treatment of infertile women with polycystic ovary syndrome (PCOS) is surrounded by
many controversies. This paper describes, on the basis of the currently available evidence …

Background Polycystic ovary syndrome (PCOS) is characterised by infrequent or absent
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …

Polycystic ovary syndrome (PCOS) is a very common endocrine disorder characterized by
chronic anovulation, clinical and/or biochemical hyperandrogenism, and/or polycystic …

The aetiology of polycystic ovary syndrome (PCOS) remains unknown. This familial
syndrome is prevalent among reproductive-aged women and its inheritance indicates a …

Insulin has complex effects on cell growth, metabolism and differentiation, and these effects
are mediated by a cell-surface bound receptor and eventually a cascade of intracellular …